Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 December 2024
- Conf. stmt due
- 19 July 2027
- Last conf. stmt
- 5 July 2026
Invitech Ltd
- Incorporated
- 25 June 2008 (18 years)
- Industry
- Wholesale of pharmaceutical goods (46460)
- Directors
- Brian Wall
- Owned by
- Accounts type
- Audit exemption subsidiary
- Region
- Yorkshire
- Address
- Unit 5A - Calibre Scientific House Selden WayCatcliffeRotherhamS60 5XA
Charges
- Total
- 3
- Outstanding
- 3
- Part satisfied
- 0
- Satisfied
- 0
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 1 July 2026
British
Born December 1968 (57)
Director · Appointed 1 July 2026
American
Born February 1988 (38)
Wall, Brian
Director · Appointed 30 August 2024
American
Born June 1973 (53)
Officer history (6 former)
1 July 2026
1 July 2026
30 June 2026
30 June 2026
2 June 2025
31 May 2025
1 January 2025
31 December 2024
30 August 2024
Appointed Wall, Brian as Director
30 August 2024
30 August 2024
30 August 2024
Resigned Younghusband, Suzanne as Director
30 August 2024
Resigned Younghusband, Michael Gordon as Director
2 August 2011
Appointed Younghusband, Suzanne as Director
25 June 2008
Appointed Younghusband, Michael Gordon as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 30 August 2024
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited Company
Reg. no. 01794026
Former controllers (2)
30 August 2024
Ceased Michael Younghusband — Owns 25–50% of shares
30 August 2024
Ceased Suzanne Younghusband — Owns 25–50% of shares
Group structure 19 shown
Ownership group derived from the Companies House PSC register
Agar International Limited Owns 75–100% of shares
Agar Scientific Limited Owns 75–100% of shares
Ampcs Limited Owns 75–100% of shares
BB3 Holdings Ltd Owns 75–100% of shares
Sciquip Limited Owns 75–100% of shares
Bond Chemicals Limited Owns 75–100% of shares
Camlab Limited Owns 75–100% of shares
The Labsales Company Limited Owns 75–100% of shares
Conex Chromatography Systems Ltd. Owns 75–100% of shares
Elkay Laboratory Products (U.K.) Limited Owns 75–100% of shares
Environmental Validation Solutions Limited Owns 75–100% of shares
Greyhound Chromatography and Allied Chemicals Limited Owns 75–100% of shares
Invitech Ltd This company Owns 75–100% of shares
Labtech International Ltd Owns 75–100% of shares
Lorne Laboratories Limited Owns 75–100% of shares
Medline Scientific Limited Owns 75–100% of shares
Microm UK Limited Owns 75–100% of shares
Financials
Figures from 2023 accounts. Newer accounts, made up to 31 December 2024, are filed but not read yet. See them on Companies House
- Net Assets
- £316,504
- Cash
- £263,692
- Employees
- 3
- Debt Ratio
- 41%
- Current Ratio
- 2.2x
Trend
Net Assets
Balance sheet detail
| 2023 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Fixed Assets | £60,600 | £19,898 | £7,588 | £9,492 |
| Current Assets | £478,962 | £539,052 | £291,903 | £443,894 |
| Debtors | £78,234 | £52,235 | £54,869 | £97,850 |
| Cash | £263,692 | £412,940 | £194,230 | £259,090 |
| Creditors (< 1 year) | £214,670 | £283,636 | £116,110 | £217,502 |
| Net Current Assets | £264,292 | £255,416 | £175,793 | £226,392 |
| Net Assets | £316,504 | £280,005 | £188,542 | £241,068 |
| Shareholder Funds | £316,504 | £280,005 | £188,542 | £241,068 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 26 July 2026 | Confirmation statement with no updates | 5 July 2026 | ||
| 15 July 2026 | Appointment of a director | |||
| 15 July 2026 | Appointment of a director | |||
| 14 July 2026 | Termination of appointment of a director | |||
| 14 July 2026 | Termination of appointment of a director |
Some other companies at this address
Other companies in this industry
Loughton
London
Hitchin
Birmingham
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →